¹⁸F-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment

10.1007/s11060-004-8093-6

10.1200/JCO.2004.12.149

Cavaliere, 2006, Cerebral metastases: a therapeutic update, Nat Clin Pract Neurol., 2, 426, 10.1038/ncpneuro0263

10.1002/cncr.24333

10.1093/annonc/mdr022

10.1159/000076903

Ellis TL Neal MT Chan MD . The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors. Int J Surg Oncol. 2012;2012:952345.

10.1016/j.ijrobp.2005.12.002

Levivier, 1996, Radiation necrosis or recurrence, J Neurosurg., 84, 148

10.1007/s11910-009-0035-4

10.1007/s11060-012-0881-9

10.1016/j.ejrad.2008.08.009

10.2967/jnumed.106.037689

10.1002/ijc.1016

Ricci, 1998, Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?, AJNR Am J Neuroradiol., 19, 407

10.1227/01.NEU.0000057745.48813.93

10.1016/j.ijrobp.2010.07.002

Chen, 2006, 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy, J Nucl Med., 47, 904

10.1016/0883-2889(92)90217-3

10.1016/0969-8051(95)02037-3

10.1097/00004728-198204000-00022

10.1118/1.598392

10.1109/42.925290

10.1148/radiology.211.3.r99jn48807

Macdonald, 1990, Response criteria for phase II studies of supratentorial malignant glioma, J Clin Oncol., 8, 1277, 10.1200/JCO.1990.8.7.1277

Patronas, 1982, Work in progress: [18F]fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain, Radiology., 144, 885, 10.1148/radiology.144.4.6981123

10.3171/jns.1995.83.4.0657

Spence, 2004, 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter, J Nucl Med., 45, 1653

10.1007/s11060-010-0365-8

Heiss, 1996, F-DOPA as an amino acid tracer to detect brain tumors, J Nucl Med., 37, 1180

10.2967/jnumed.106.039321

Oldendorf, 1976, Amino acid assignment to one of the three blood-brain barrier amino acid carriers, Am J Physiol., 230, 94, 10.1152/ajplegacy.1976.230.1.94

10.1111/j.1471-4159.1975.tb04415.x

10.1177/1073858409338217

10.2967/jnumed.107.048082

10.2967/jnumed.112.103325

Patil CG Pricola K Sarmiento JM Garg SK Bryant A Black KL . Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev. 2012;(9):CD006121.

10.1016/0022-510X(95)00117-K